Asarina Pharma receives approval of CTA for phase IIa Tourette study
(Stockholm, 19 May, 2021.) Asarina Pharma’s Clinical Trial Application for a phase IIa study with Sepranolone in Tourette Syndrome has been approved by the Danish… Read More »Asarina Pharma receives approval of CTA for phase IIa Tourette study